55675-86-0

Basic information

• Product Name: 4-aMinobiphenyl-3-carbonitrile
• Synonyms: [1,1'-Biphenyl]-3-carbonitrile, 4-amino-
• CAS NO: 55675-86-0
• Molecular Formula: C₁₃H₁₀N₂
• Molecular Weight: 194.2319
• EINECS: -0
• Mol File: 55675-86-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-aMinobiphenyl-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-aMinobiphenyl-3-carbonitrile(55675-86-0)
• EPA Substance Registry System: 4-aMinobiphenyl-3-carbonitrile(55675-86-0)

Safety Data

• Hazardous Substances Data: 55675-86-0(Hazardous Substances Data)

Usage

General Description

4-Aminobiphenyl-3-carbonitrile, also known as 3-cyano-4-aminobiphenyl, is a chemical compound with the molecular formula C13H10N2. It is a pale yellow solid that is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 4-Aminobiphenyl-3-carbonitrile is also employed as a building block in the production of dyes, pigments, and other organic compounds. It is considered to have low acute toxicity, but its potential chronic health effects are still under investigation. The compound's reactivity and potential hazards should be carefully considered when handling and using it in any application.

Upstream product

• 1885-29-6 anthranilic acid nitrile 
• 39263-32-6 2-amino-5-bromobenzonitrile 
• 98-80-6 phenylboronic acid 

Relevant articles and documents

PFKFB3 INHIBITORS AND THEIR USES

This disclosure relates to new phthalimide and isoindolinone derivatives and other PFKFB3 inhibitors for use in the treatment of diseases. The invention further relates to pharmaceutical compositions containing such PFKFB3 inhibitors, methods of preparation thereof, methods for their use as therapeutic agents, and methods of preparation of a medicament for use in therapy, as well as kits and other inventiions comprising such PFKFB3 inhibitors. These PFKFB3 inhibitors are useful for the treatment and prophylaxis of cancer, neurodegenerative diseases, autoimmune diseases, inflammatory disorders, multiple sclerosis, metabolic diseases, inhibition of angiogenesis and other diseases and conditions, where the modulation of PFKFB3 and/or PFKFB4 has beneficial effect as well as neuroprotection.

Heterocyclic compound and organic light-emitting device comprising the same

Disclosed are a heterocyclic compound and an organic light-emitting device comprising the same. The heterocyclic compound is represented by chemical formula 1. The organic light-emitting device comprising the heterocyclic compound can have low driving voltage, high brightness, high efficiency, and long lifespan.COPYRIGHT KIPO 2016

An electroluminescent compound and an electroluminescent device comprising the same

The present invention relates to organic light emitting compounds represented by chemical formula 1-1 to chemical formula 1-2. An organic electroluminescent device using the same has excellent light emitting efficiency and can be driven at low voltage, thereby having improved power efficiency and long life characteristics.COPYRIGHT KIPO 2015